Last reviewed · How we verify
NCT05743816: neoAMRO
Neonatal Antimicrobial Resistance and Outcome
trial in Neonatal Infection in 800 participants. Status unknown.
30 September 2023
Quick facts
| Lead sponsor | St George's, University of London |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 800 |
| Start date | 30 July 2019 |
| Primary completion | 30 September 2023 |
| Estimated completion | 29 February 2024 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Neonatal Infection — all drugs for Neonatal Infection →
Sponsor
St George's, University of London
Who can join
Adults 28 Days to 12 Months, any sex, with Neonatal Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multicentre observational study involving NNUs across the UK. Study personnel (Neonatologists and research Nurses) from these NNUs will identify eligible babies in whom a positive culture has been obtained. This study will help identify the infections leading to death in babies on UK neonatal units, define the clinical characteristics of babies dying from infections, and describe the management of babies dying from infections with a specific focus in their antimicrobial treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05743816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Infection
Currently open trials in the same condition.
- NCT06592586 — A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women · Phase 2, PHASE3 · active not recruiting
- NCT06656104 — Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections · recruiting
- NCT06102044 — Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania · Phase 3 · recruiting
- NCT06283355 — Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome · Phase 1 · recruiting
- NCT05695196 — Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant · Phase 1 · active not recruiting
Other St George's, University of London trials
Trials by the same sponsor.
- NCT07012421 — Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI) · recruiting
- NCT06411405 — Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe · unknown
- NCT05950984 — Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK) · completed
- NCT05855889 — Observational Study of the Management of Infants With Congenital CMV · recruiting
- NCT06159218 — Eosinophilic Oesophagitis Assessment With String Testing · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05743816 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St George's, University of London
- Last refreshed: 1 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05743816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing